Adolescent girls and young women HIV/SRH integration
This indicator measures the integration of HIV testing with sexual and reproductive health services by assessing the extent to which adolescent girls and young women seeking contraception are tested for HIV.
- Adolescent girls and young women seeking contraceptive/family planning services often engage in unprotected sexual intercourse, which puts them at risk for HIV infection in high HIV burden and incidence settings (for example, Southern Africa, where HIV incidence is particularly high among adolescent girls and young women).
- The Evidence for Contraceptive Options in HIV Outcomes (ECHO) trial showed a high incidence of HIV infection among all women seeking contraception, especially women under 25 years. In high HIV burden and incidence settings such as Southern Africa, programmes should strengthen the integration of HIV prevention with contraceptive and other sexual and reproductive health services.
- HIV testing serves as a first step in linkage to ART for those testing HIV-positive and to condom promotion and, where appropriate, PrEP for those testing HIV-negative.
Number of adolescent girls and women seeking contraception/family planning services who were tested for HIV
Number of adolescent girls and women seeking contraception/family planning services
For the numerator and denominator. Programme records; registers of contraception/sexual/reproductive health clinics could be used. Currently, HIV testing and referral to prevention or treatment are infrequently captured by reproductive health services. New strategies and materials for collecting this indicator may be needed.
The intended focus of this indicator is adolescent girls and young women, ages 10-24 years, assessed by reviewing results by 5-year age bands up to the age of 24 years. The broader inclusion of women of reproductive age over the age of 25 serves as a comparison to identify trends among adolescent girls and young women.
- Age (10-14, 15-19, 20-24, 25-49, 50+)
- HIV test status (negative, positive, indeterminate).
Additional recommendations for settings with robust electronic HIS, for example, EMRs:
- Referral to/uptake of prevention (for example, PrEP) and treatment services that may reduce new infections
- HIV testing approach (for example, rapid diagnostic test, HIV self-testing, referral to HTS).
WHO Strategic Information Guidelines, 2020 (https://indicatorregistry.unaids.org/sites/default/files/9789240000735-eng.pdf)